diverticulitis semaglutide Semaglutide, Ozempic & Diverticulitis: Gut

Weight loss injections primarily refer to glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes management but now FDA-approved for chronic weight management in adults with BMI 30 kg/m (or 27 kg/m with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia)

Weight loss often becomes noticeable on the scale

By understanding the factors that contribute to pancreatitis risk, individuals can take proactive steps to mitigate these risks while benefiting from the medications weight loss effects

Tirzepatide and exercise training in obesity